Our consultants have supported successful development and registration of 16 new drugs for the treatment of ADHD, binge-eating disorder, schizophrenia, opiate withdrawal, opiate-induced constipation, Parkinson’s disease, epilepsy, anaesthesia, obesity and type 2 diabetes. DevelRx are world experts on in market positioning and drug lifecycle management.
Our services include:
- Strategic planning for pharmacological profiling and market positioning of a drug in development
- Positioning of a new drug in additional therapeutic areas - we design, place and manage non-clinical studies
- Lifecycle management including new therapeutic indications for marketed drugs
- Strategic reviews of a therapeutic indication including market opportunities, barriers to market entry and likelihood of success
- Scientific advisory board participation
- Evaluation of licencing opportunities
- Due diligence reviews
- Preparation of patents to help our clients maintain intellectual property for their drug inventions
- Expert witness work - we offer advice to legal representatives of the pharmaceutical industry, to generic drug-makers and to government agencies. We support litigation in areas including intellectual property disputes and claims relating to drug efficacy and safety by providing expert testimony as written depositions. We can also provide expert witness testimony in court
- Medical education - training of scientists and clinicians at client hosted symposia, preparation of articles for specialist journals, and participating in webinars and films
Get in touch to find out how we can help you.